solid , 37762-06-4
Synonym(s):
1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one;1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidine-7-one, M&B22948;Zaprinast - CAS 37762-06-4 - Calbiochem
CAS NO.:37762-06-4
Empirical Formula: C13H13N5O2
Molecular Weight: 271.27
MDL number: MFCD00214073
EINECS: 253-655-1
Pack Size | Price | Stock | Quantity |
25mg | RMB808.18 | In Stock |
|
100mg | RMB2633.35 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 237-238°C dec. |
Density | 1.48±0.1 g/cm3(Predicted) |
RTECS | XZ6157358 |
storage temp. | Store at RT |
solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.11 mg/mL |
form | solid |
pka | 6.92±0.20(Predicted) |
color | white |
Description and Uses
The cyclic nucleotide second messenger guanosine 3’5’-
Zaprinast is a selective inhibitor of cyclic-GMP phosphodiesterase (PDE V, calmodulin insensitive). Since cGMP mediates the vasorelaxant action of nitric oxide, as well as the natriuretic and diuretic effect of at rial natriuretic factor (ANF) through the activation of PKG (cGMP dependent protein kinase), such inhibitors may display vasodilating, relaxant, and diuretic effects. These compounds may prove useful in treating hypertension and congestive heart failure.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
WGK Germany | 3 |